Metastatic Breast Cancer | Tumor

FDA Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer

February 27th 2018, 5:12am

The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.

Living Or Living With Cancer

February 23rd 2018, 9:47pm

Using some simple reminders that life is still happening can help put cancer anxiety and fear back where they belong.

What's Next And Other Things Metastatic Patients Want to Know

February 19th 2018, 7:56pm

Individual advocates and larger organizations offer hope as they help us understand what future treatments are in the pipeline.

Patients Concerned as Humana Takes Herceptin Off Preferred Drug List in South Florida

January 30th 2018, 6:56pm

Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.

Individual Knowledge Is Power in Addressing BRCA Gene Mutations

January 29th 2018, 9:14pm

As costs decrease, and physicians move to address barriers to genetic testing, a panel of physicians, researchers and a patient advocate highlighted the importance for people to get tested.

FDA Approves Lynparza for BRCA-Positive Breast Cancer

January 12th 2018, 8:43pm

Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.

CDK4/6 Inhibitors in Metastatic Disease

January 11th 2018, 11:47pm

Goals of Therapy in Metastatic Breast Cancer

January 11th 2018, 11:47pm

Management of Triple-negative Breast Cancer

January 11th 2018, 11:47pm

Considerations When Treating With Hormone Therapy

January 11th 2018, 11:47pm